Index by author

November 01, 1998; Volume 9,Issue 11

Looking for COVID information? All ASN Journal COVID articles are in the COVID-19 Research Collection or the COVID-19 In Context Collection. All articles are free.​

A

  1. Adrogué, H J

    1. Low dialysate [K+] decreases efficiency of hemodialysis and increases urea rebound.
      G M Dolson and H J Adrogué
      JASN November 1998, 9 (11) 2124-2128; DOI: https://doi.org/10.1681/ASN.V9112124

  2. Agarwal, A

    1. Linoleyl hydroperoxide transcriptionally upregulates heme oxygenase-1 gene expression in human renal epithelial and aortic endothelial cells.
      A Agarwal, F Shiraishi, G A Visner and H S Nick
      JASN November 1998, 9 (11) 1990-1997; DOI: https://doi.org/10.1681/ASN.V9111990

  3. Alvarez Arroyo, M V

    1. Role of vascular endothelial growth factor on erythropoietin-related endothelial cell proliferation.
      M V Alvarez Arroyo, M A Castilla, F R González Pacheco, D Tan, A Riesco, S Casado and C Caramelo
      JASN November 1998, 9 (11) 1998-2004; DOI: https://doi.org/10.1681/ASN.V9111998

B

  1. Benini, R

    1. Effects of dihydropyridine calcium channel blockers, angiotensin-converting enzyme inhibition, and blood pressure control on chronic, nondiabetic nephropathies. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN).
      P Ruggenenti, A Perna, R Benini and G Remuzzi
      JASN November 1998, 9 (11) 2096-2101; DOI: https://doi.org/10.1681/ASN.V9112096

  2. Bianchi, G

    1. Donor and recipient family histories of hypertension influence renal impairment and blood pressure during acute rejections.
      E Guidi, M G Cozzi, E Minetti and G Bianchi
      JASN November 1998, 9 (11) 2102-2107; DOI: https://doi.org/10.1681/ASN.V9112102

  3. Breiteneder-Geleff, S

    1. Epitope-specific antibodies to the 43-kD glomerular membrane protein podoplanin cause proteinuria and rapid flattening of podocytes.
      K Matsui, S Breiteneder-Geleff and D Kerjaschki
      JASN November 1998, 9 (11) 2013-2026; DOI: https://doi.org/10.1681/ASN.V9112013

  4. Broekroelofs, J

    1. Risk factors for long-term renal survival after renal transplantation: a role for angiotensin-converting enzyme (insertion/deletion) polymorphism?
      J Broekroelofs, C A Stegeman, G Navis, A M Tegzess, D De Zeeuw and P E De Jong
      JASN November 1998, 9 (11) 2075-2081; DOI: https://doi.org/10.1681/ASN.V9112075

C

  1. Caramelo, C

    1. Role of vascular endothelial growth factor on erythropoietin-related endothelial cell proliferation.
      M V Alvarez Arroyo, M A Castilla, F R González Pacheco, D Tan, A Riesco, S Casado and C Caramelo
      JASN November 1998, 9 (11) 1998-2004; DOI: https://doi.org/10.1681/ASN.V9111998

  2. Casado, S

    1. Role of vascular endothelial growth factor on erythropoietin-related endothelial cell proliferation.
      M V Alvarez Arroyo, M A Castilla, F R González Pacheco, D Tan, A Riesco, S Casado and C Caramelo
      JASN November 1998, 9 (11) 1998-2004; DOI: https://doi.org/10.1681/ASN.V9111998

  3. Castilla, M A

    1. Role of vascular endothelial growth factor on erythropoietin-related endothelial cell proliferation.
      M V Alvarez Arroyo, M A Castilla, F R González Pacheco, D Tan, A Riesco, S Casado and C Caramelo
      JASN November 1998, 9 (11) 1998-2004; DOI: https://doi.org/10.1681/ASN.V9111998

  4. Chan, J C

    1. Glomerulosclerosis in the remnant kidney rat is modulated by dietary alpha-tocopherol.
      S Hahn, N B Kuemmerle, W Chan, S Hisano, P Saborio, R J Krieg and J C Chan
      JASN November 1998, 9 (11) 2089-2095; DOI: https://doi.org/10.1681/ASN.V9112089

  5. Chan, W

    1. Glomerulosclerosis in the remnant kidney rat is modulated by dietary alpha-tocopherol.
      S Hahn, N B Kuemmerle, W Chan, S Hisano, P Saborio, R J Krieg and J C Chan
      JASN November 1998, 9 (11) 2089-2095; DOI: https://doi.org/10.1681/ASN.V9112089

  6. Charmes, J P

    1. Decrease of serum paraoxonase activity in chronic renal failure.
      T F Dantoine, J Debord, J P Charmes, L Merle, P Marquet, G Lachatre and C Leroux-Robert
      JASN November 1998, 9 (11) 2082-2088; DOI: https://doi.org/10.1681/ASN.V9112082

  7. Cheang, M

    1. Beneficial effects of treatment of early subclinical rejection: a randomized study.
      D Rush, P Nickerson, J Gough, R McKenna, P Grimm, M Cheang, K Trpkov, K Solez and J Jeffery
      JASN November 1998, 9 (11) 2129-2134; DOI: https://doi.org/10.1681/ASN.V9112129

  8. Collins, A J

    1. Dialysis unit and patient characteristics associated with reuse practices and mortality: 1989-1993.
      A J Collins, J Z Ma, E G Constantini and S E Everson
      JASN November 1998, 9 (11) 2108-2117; DOI: https://doi.org/10.1681/ASN.V9112108

  9. Constantini, E G

    1. Dialysis unit and patient characteristics associated with reuse practices and mortality: 1989-1993.
      A J Collins, J Z Ma, E G Constantini and S E Everson
      JASN November 1998, 9 (11) 2108-2117; DOI: https://doi.org/10.1681/ASN.V9112108

  10. Cozzi, M G

    1. Donor and recipient family histories of hypertension influence renal impairment and blood pressure during acute rejections.
      E Guidi, M G Cozzi, E Minetti and G Bianchi
      JASN November 1998, 9 (11) 2102-2107; DOI: https://doi.org/10.1681/ASN.V9112102

  11. Curtis, J J

    1. Living unrelated renal transplantation: progress and potential.
      M R Said and J J Curtis
      JASN November 1998, 9 (11) 2148-2152; DOI: https://doi.org/10.1681/ASN.V9112148

D

  1. Daniel, C

    1. Mycophenolic acid: a new approach to the therapy of experimental mesangial proliferative glomerulonephritis.
      R Ziswiler, K Steinmann-Niggli, A Kappeler, C Daniel and H P Marti
      JASN November 1998, 9 (11) 2055-2066; DOI: https://doi.org/10.1681/ASN.V9112055

  2. Dantoine, T F

    1. Decrease of serum paraoxonase activity in chronic renal failure.
      T F Dantoine, J Debord, J P Charmes, L Merle, P Marquet, G Lachatre and C Leroux-Robert
      JASN November 1998, 9 (11) 2082-2088; DOI: https://doi.org/10.1681/ASN.V9112082

  3. Debord, J

    1. Decrease of serum paraoxonase activity in chronic renal failure.
      T F Dantoine, J Debord, J P Charmes, L Merle, P Marquet, G Lachatre and C Leroux-Robert
      JASN November 1998, 9 (11) 2082-2088; DOI: https://doi.org/10.1681/ASN.V9112082

  4. De Jong, P E

    1. Risk factors for long-term renal survival after renal transplantation: a role for angiotensin-converting enzyme (insertion/deletion) polymorphism?
      J Broekroelofs, C A Stegeman, G Navis, A M Tegzess, D De Zeeuw and P E De Jong
      JASN November 1998, 9 (11) 2075-2081; DOI: https://doi.org/10.1681/ASN.V9112075

  5. De Zeeuw, D

    1. Risk factors for long-term renal survival after renal transplantation: a role for angiotensin-converting enzyme (insertion/deletion) polymorphism?
      J Broekroelofs, C A Stegeman, G Navis, A M Tegzess, D De Zeeuw and P E De Jong
      JASN November 1998, 9 (11) 2075-2081; DOI: https://doi.org/10.1681/ASN.V9112075

  6. Dibona, G F

    1. Effect of endogenous angiotensin II on renal nerve activity and its cardiac baroreflex regulation.
      G F Dibona, S Y Jones and L L Sawin
      JASN November 1998, 9 (11) 1983-1989; DOI: https://doi.org/10.1681/ASN.V9111983

  7. Dolson, G M

    1. Low dialysate [K+] decreases efficiency of hemodialysis and increases urea rebound.
      G M Dolson and H J Adrogué
      JASN November 1998, 9 (11) 2124-2128; DOI: https://doi.org/10.1681/ASN.V9112124

E

  1. Elliot, S J

    1. Glomerular endothelial cells synthesize collagens but little gelatinase A and B.
      O Lenz, L J Striker, T A Jacot, S J Elliot, P D Killen and G E Striker
      JASN November 1998, 9 (11) 2040-2047; DOI: https://doi.org/10.1681/ASN.V9112040

  2. Ellison, M D

    1. Race and socioeconomic factors influencing early placement on the kidney transplant waiting list.
      B L Kasiske, W London and M D Ellison
      JASN November 1998, 9 (11) 2142-2147; DOI: https://doi.org/10.1681/ASN.V9112142

  3. Everson, S E

    1. Dialysis unit and patient characteristics associated with reuse practices and mortality: 1989-1993.
      A J Collins, J Z Ma, E G Constantini and S E Everson
      JASN November 1998, 9 (11) 2108-2117; DOI: https://doi.org/10.1681/ASN.V9112108

F

  1. Fricke, H

    1. High glucose increases prostaglandin E2 synthesis in human peritoneal mesothelial cells: role of hyperosmolarity.
      T Sitter, B Haslinger, S Mandl, H Fricke, E Held and A Sellmayer
      JASN November 1998, 9 (11) 2005-2012; DOI: https://doi.org/10.1681/ASN.V9112005

G

  1. González Pacheco, F R

    1. Role of vascular endothelial growth factor on erythropoietin-related endothelial cell proliferation.
      M V Alvarez Arroyo, M A Castilla, F R González Pacheco, D Tan, A Riesco, S Casado and C Caramelo
      JASN November 1998, 9 (11) 1998-2004; DOI: https://doi.org/10.1681/ASN.V9111998

  2. Gough, J

    1. Beneficial effects of treatment of early subclinical rejection: a randomized study.
      D Rush, P Nickerson, J Gough, R McKenna, P Grimm, M Cheang, K Trpkov, K Solez and J Jeffery
      JASN November 1998, 9 (11) 2129-2134; DOI: https://doi.org/10.1681/ASN.V9112129

  3. Grimm, P

    1. Beneficial effects of treatment of early subclinical rejection: a randomized study.
      D Rush, P Nickerson, J Gough, R McKenna, P Grimm, M Cheang, K Trpkov, K Solez and J Jeffery
      JASN November 1998, 9 (11) 2129-2134; DOI: https://doi.org/10.1681/ASN.V9112129

  4. Groves, C E

    1. Peritubular transport of ochratoxin A by single rabbit renal proximal tubules.
      J R Welborn, C E Groves and S H Wright
      JASN November 1998, 9 (11) 1973-1982; DOI: https://doi.org/10.1681/ASN.V9111973

  5. Guidi, E

    1. Donor and recipient family histories of hypertension influence renal impairment and blood pressure during acute rejections.
      E Guidi, M G Cozzi, E Minetti and G Bianchi
      JASN November 1998, 9 (11) 2102-2107; DOI: https://doi.org/10.1681/ASN.V9112102

H

  1. Hahn, S

    1. Glomerulosclerosis in the remnant kidney rat is modulated by dietary alpha-tocopherol.
      S Hahn, N B Kuemmerle, W Chan, S Hisano, P Saborio, R J Krieg and J C Chan
      JASN November 1998, 9 (11) 2089-2095; DOI: https://doi.org/10.1681/ASN.V9112089

  2. Haslinger, B

    1. High glucose increases prostaglandin E2 synthesis in human peritoneal mesothelial cells: role of hyperosmolarity.
      T Sitter, B Haslinger, S Mandl, H Fricke, E Held and A Sellmayer
      JASN November 1998, 9 (11) 2005-2012; DOI: https://doi.org/10.1681/ASN.V9112005

  3. Held, E

    1. High glucose increases prostaglandin E2 synthesis in human peritoneal mesothelial cells: role of hyperosmolarity.
      T Sitter, B Haslinger, S Mandl, H Fricke, E Held and A Sellmayer
      JASN November 1998, 9 (11) 2005-2012; DOI: https://doi.org/10.1681/ASN.V9112005

  4. Hiki, Y

    1. Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins.
      T Kokubo, Y Hiki, H Iwase, A Tanaka, K Toma, K Hotta and Y Kobayashi
      JASN November 1998, 9 (11) 2048-2054; DOI: https://doi.org/10.1681/ASN.V9112048

  5. Hisano, S

    1. Glomerulosclerosis in the remnant kidney rat is modulated by dietary alpha-tocopherol.
      S Hahn, N B Kuemmerle, W Chan, S Hisano, P Saborio, R J Krieg and J C Chan
      JASN November 1998, 9 (11) 2089-2095; DOI: https://doi.org/10.1681/ASN.V9112089

  6. Hotta, K

    1. Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins.
      T Kokubo, Y Hiki, H Iwase, A Tanaka, K Toma, K Hotta and Y Kobayashi
      JASN November 1998, 9 (11) 2048-2054; DOI: https://doi.org/10.1681/ASN.V9112048

I

  1. Ideura, T

    1. Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis.
      A Yoshimura, K Inui, T Nemoto, S Uda, Y Sugenoya, S Watanabe, N Yokota, T Taira, S Iwasaki and T Ideura
      JASN November 1998, 9 (11) 2027-2039; DOI: https://doi.org/10.1681/ASN.V9112027

  2. Inui, K

    1. Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis.
      A Yoshimura, K Inui, T Nemoto, S Uda, Y Sugenoya, S Watanabe, N Yokota, T Taira, S Iwasaki and T Ideura
      JASN November 1998, 9 (11) 2027-2039; DOI: https://doi.org/10.1681/ASN.V9112027

  3. Iwasaki, S

    1. Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis.
      A Yoshimura, K Inui, T Nemoto, S Uda, Y Sugenoya, S Watanabe, N Yokota, T Taira, S Iwasaki and T Ideura
      JASN November 1998, 9 (11) 2027-2039; DOI: https://doi.org/10.1681/ASN.V9112027

  4. Iwase, H

    1. Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins.
      T Kokubo, Y Hiki, H Iwase, A Tanaka, K Toma, K Hotta and Y Kobayashi
      JASN November 1998, 9 (11) 2048-2054; DOI: https://doi.org/10.1681/ASN.V9112048

J

  1. Jacot, T A

    1. Glomerular endothelial cells synthesize collagens but little gelatinase A and B.
      O Lenz, L J Striker, T A Jacot, S J Elliot, P D Killen and G E Striker
      JASN November 1998, 9 (11) 2040-2047; DOI: https://doi.org/10.1681/ASN.V9112040

  2. Jeffery, J

    1. Beneficial effects of treatment of early subclinical rejection: a randomized study.
      D Rush, P Nickerson, J Gough, R McKenna, P Grimm, M Cheang, K Trpkov, K Solez and J Jeffery
      JASN November 1998, 9 (11) 2129-2134; DOI: https://doi.org/10.1681/ASN.V9112129

  3. Jones, S Y

    1. Effect of endogenous angiotensin II on renal nerve activity and its cardiac baroreflex regulation.
      G F Dibona, S Y Jones and L L Sawin
      JASN November 1998, 9 (11) 1983-1989; DOI: https://doi.org/10.1681/ASN.V9111983

K

  1. Kappeler, A

    1. Mycophenolic acid: a new approach to the therapy of experimental mesangial proliferative glomerulonephritis.
      R Ziswiler, K Steinmann-Niggli, A Kappeler, C Daniel and H P Marti
      JASN November 1998, 9 (11) 2055-2066; DOI: https://doi.org/10.1681/ASN.V9112055

  2. Kasiske, B L

    1. Race and socioeconomic factors influencing early placement on the kidney transplant waiting list.
      B L Kasiske, W London and M D Ellison
      JASN November 1998, 9 (11) 2142-2147; DOI: https://doi.org/10.1681/ASN.V9112142

  3. Kerjaschki, D

    1. Epitope-specific antibodies to the 43-kD glomerular membrane protein podoplanin cause proteinuria and rapid flattening of podocytes.
      K Matsui, S Breiteneder-Geleff and D Kerjaschki
      JASN November 1998, 9 (11) 2013-2026; DOI: https://doi.org/10.1681/ASN.V9112013

  4. Killen, P D

    1. Glomerular endothelial cells synthesize collagens but little gelatinase A and B.
      O Lenz, L J Striker, T A Jacot, S J Elliot, P D Killen and G E Striker
      JASN November 1998, 9 (11) 2040-2047; DOI: https://doi.org/10.1681/ASN.V9112040

  5. Kimmel, P L

    1. Dialyzer reuse and the treatment of patients with end-stage renal disease by hemodialysis.
      P L Kimmel and G J Mishkin
      JASN November 1998, 9 (11) 2153-2156; DOI: https://doi.org/10.1681/ASN.V9112153

  6. Kobayashi, Y

    1. Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins.
      T Kokubo, Y Hiki, H Iwase, A Tanaka, K Toma, K Hotta and Y Kobayashi
      JASN November 1998, 9 (11) 2048-2054; DOI: https://doi.org/10.1681/ASN.V9112048

  7. Kokubo, T

    1. Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins.
      T Kokubo, Y Hiki, H Iwase, A Tanaka, K Toma, K Hotta and Y Kobayashi
      JASN November 1998, 9 (11) 2048-2054; DOI: https://doi.org/10.1681/ASN.V9112048

  8. Krieg, R J

    1. Glomerulosclerosis in the remnant kidney rat is modulated by dietary alpha-tocopherol.
      S Hahn, N B Kuemmerle, W Chan, S Hisano, P Saborio, R J Krieg and J C Chan
      JASN November 1998, 9 (11) 2089-2095; DOI: https://doi.org/10.1681/ASN.V9112089

  9. Kuemmerle, N B

    1. Glomerulosclerosis in the remnant kidney rat is modulated by dietary alpha-tocopherol.
      S Hahn, N B Kuemmerle, W Chan, S Hisano, P Saborio, R J Krieg and J C Chan
      JASN November 1998, 9 (11) 2089-2095; DOI: https://doi.org/10.1681/ASN.V9112089

L

  1. Lachatre, G

    1. Decrease of serum paraoxonase activity in chronic renal failure.
      T F Dantoine, J Debord, J P Charmes, L Merle, P Marquet, G Lachatre and C Leroux-Robert
      JASN November 1998, 9 (11) 2082-2088; DOI: https://doi.org/10.1681/ASN.V9112082

  2. Lenz, O

    1. Glomerular endothelial cells synthesize collagens but little gelatinase A and B.
      O Lenz, L J Striker, T A Jacot, S J Elliot, P D Killen and G E Striker
      JASN November 1998, 9 (11) 2040-2047; DOI: https://doi.org/10.1681/ASN.V9112040

  3. Leroux-Robert, C

    1. Decrease of serum paraoxonase activity in chronic renal failure.
      T F Dantoine, J Debord, J P Charmes, L Merle, P Marquet, G Lachatre and C Leroux-Robert
      JASN November 1998, 9 (11) 2082-2088; DOI: https://doi.org/10.1681/ASN.V9112082

  4. London, W

    1. Race and socioeconomic factors influencing early placement on the kidney transplant waiting list.
      B L Kasiske, W London and M D Ellison
      JASN November 1998, 9 (11) 2142-2147; DOI: https://doi.org/10.1681/ASN.V9112142

  5. Lorenz, D

    1. Impact of renal cadaveric transplantation on survival in end-stage renal failure: evidence for reduced mortality risk compared with hemodialysis during long-term follow-up.
      P Schnuelle, D Lorenz, M Trede and F J Van Der Woude
      JASN November 1998, 9 (11) 2135-2141; DOI: https://doi.org/10.1681/ASN.V9112135

M

  1. Ma, J Z

    1. Dialysis unit and patient characteristics associated with reuse practices and mortality: 1989-1993.
      A J Collins, J Z Ma, E G Constantini and S E Everson
      JASN November 1998, 9 (11) 2108-2117; DOI: https://doi.org/10.1681/ASN.V9112108

  2. Mandl, S

    1. High glucose increases prostaglandin E2 synthesis in human peritoneal mesothelial cells: role of hyperosmolarity.
      T Sitter, B Haslinger, S Mandl, H Fricke, E Held and A Sellmayer
      JASN November 1998, 9 (11) 2005-2012; DOI: https://doi.org/10.1681/ASN.V9112005

  3. Marquet, P

    1. Decrease of serum paraoxonase activity in chronic renal failure.
      T F Dantoine, J Debord, J P Charmes, L Merle, P Marquet, G Lachatre and C Leroux-Robert
      JASN November 1998, 9 (11) 2082-2088; DOI: https://doi.org/10.1681/ASN.V9112082

  4. Marti, H P

    1. Mycophenolic acid: a new approach to the therapy of experimental mesangial proliferative glomerulonephritis.
      R Ziswiler, K Steinmann-Niggli, A Kappeler, C Daniel and H P Marti
      JASN November 1998, 9 (11) 2055-2066; DOI: https://doi.org/10.1681/ASN.V9112055

  5. Mathias, R S

    1. Reduced expression of the renal calcium-sensing receptor in rats with experimental chronic renal insufficiency.
      R S Mathias, H T Nguyen, M Y Zhang and A A Portale
      JASN November 1998, 9 (11) 2067-2074; DOI: https://doi.org/10.1681/ASN.V9112067

  6. Matsui, K

    1. Epitope-specific antibodies to the 43-kD glomerular membrane protein podoplanin cause proteinuria and rapid flattening of podocytes.
      K Matsui, S Breiteneder-Geleff and D Kerjaschki
      JASN November 1998, 9 (11) 2013-2026; DOI: https://doi.org/10.1681/ASN.V9112013

  7. McKenna, R

    1. Beneficial effects of treatment of early subclinical rejection: a randomized study.
      D Rush, P Nickerson, J Gough, R McKenna, P Grimm, M Cheang, K Trpkov, K Solez and J Jeffery
      JASN November 1998, 9 (11) 2129-2134; DOI: https://doi.org/10.1681/ASN.V9112129

  8. Merle, L

    1. Decrease of serum paraoxonase activity in chronic renal failure.
      T F Dantoine, J Debord, J P Charmes, L Merle, P Marquet, G Lachatre and C Leroux-Robert
      JASN November 1998, 9 (11) 2082-2088; DOI: https://doi.org/10.1681/ASN.V9112082

  9. Minetti, E

    1. Donor and recipient family histories of hypertension influence renal impairment and blood pressure during acute rejections.
      E Guidi, M G Cozzi, E Minetti and G Bianchi
      JASN November 1998, 9 (11) 2102-2107; DOI: https://doi.org/10.1681/ASN.V9112102

  10. Mishkin, G J

    1. Dialyzer reuse and the treatment of patients with end-stage renal disease by hemodialysis.
      P L Kimmel and G J Mishkin
      JASN November 1998, 9 (11) 2153-2156; DOI: https://doi.org/10.1681/ASN.V9112153

N

  1. Navis, G

    1. Risk factors for long-term renal survival after renal transplantation: a role for angiotensin-converting enzyme (insertion/deletion) polymorphism?
      J Broekroelofs, C A Stegeman, G Navis, A M Tegzess, D De Zeeuw and P E De Jong
      JASN November 1998, 9 (11) 2075-2081; DOI: https://doi.org/10.1681/ASN.V9112075

  2. Nemoto, T

    1. Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis.
      A Yoshimura, K Inui, T Nemoto, S Uda, Y Sugenoya, S Watanabe, N Yokota, T Taira, S Iwasaki and T Ideura
      JASN November 1998, 9 (11) 2027-2039; DOI: https://doi.org/10.1681/ASN.V9112027

  3. Nguyen, H T

    1. Reduced expression of the renal calcium-sensing receptor in rats with experimental chronic renal insufficiency.
      R S Mathias, H T Nguyen, M Y Zhang and A A Portale
      JASN November 1998, 9 (11) 2067-2074; DOI: https://doi.org/10.1681/ASN.V9112067

  4. Nick, H S

    1. Linoleyl hydroperoxide transcriptionally upregulates heme oxygenase-1 gene expression in human renal epithelial and aortic endothelial cells.
      A Agarwal, F Shiraishi, G A Visner and H S Nick
      JASN November 1998, 9 (11) 1990-1997; DOI: https://doi.org/10.1681/ASN.V9111990

  5. Nickerson, P

    1. Beneficial effects of treatment of early subclinical rejection: a randomized study.
      D Rush, P Nickerson, J Gough, R McKenna, P Grimm, M Cheang, K Trpkov, K Solez and J Jeffery
      JASN November 1998, 9 (11) 2129-2134; DOI: https://doi.org/10.1681/ASN.V9112129

P

  1. Perna, A

    1. Effects of dihydropyridine calcium channel blockers, angiotensin-converting enzyme inhibition, and blood pressure control on chronic, nondiabetic nephropathies. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN).
      P Ruggenenti, A Perna, R Benini and G Remuzzi
      JASN November 1998, 9 (11) 2096-2101; DOI: https://doi.org/10.1681/ASN.V9112096

  2. Portale, A A

    1. Reduced expression of the renal calcium-sensing receptor in rats with experimental chronic renal insufficiency.
      R S Mathias, H T Nguyen, M Y Zhang and A A Portale
      JASN November 1998, 9 (11) 2067-2074; DOI: https://doi.org/10.1681/ASN.V9112067

R

  1. Remuzzi, G

    1. Effects of dihydropyridine calcium channel blockers, angiotensin-converting enzyme inhibition, and blood pressure control on chronic, nondiabetic nephropathies. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN).
      P Ruggenenti, A Perna, R Benini and G Remuzzi
      JASN November 1998, 9 (11) 2096-2101; DOI: https://doi.org/10.1681/ASN.V9112096
    2. Nephropathy of type-2 diabetes mellitus.
      P Ruggenenti and G Remuzzi
      JASN November 1998, 9 (11) 2157-2169; DOI: https://doi.org/10.1681/ASN.V9112157

  2. Riesco, A

    1. Role of vascular endothelial growth factor on erythropoietin-related endothelial cell proliferation.
      M V Alvarez Arroyo, M A Castilla, F R González Pacheco, D Tan, A Riesco, S Casado and C Caramelo
      JASN November 1998, 9 (11) 1998-2004; DOI: https://doi.org/10.1681/ASN.V9111998

  3. Ruggenenti, P

    1. Effects of dihydropyridine calcium channel blockers, angiotensin-converting enzyme inhibition, and blood pressure control on chronic, nondiabetic nephropathies. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN).
      P Ruggenenti, A Perna, R Benini and G Remuzzi
      JASN November 1998, 9 (11) 2096-2101; DOI: https://doi.org/10.1681/ASN.V9112096
    2. Nephropathy of type-2 diabetes mellitus.
      P Ruggenenti and G Remuzzi
      JASN November 1998, 9 (11) 2157-2169; DOI: https://doi.org/10.1681/ASN.V9112157

  4. Rush, D

    1. Beneficial effects of treatment of early subclinical rejection: a randomized study.
      D Rush, P Nickerson, J Gough, R McKenna, P Grimm, M Cheang, K Trpkov, K Solez and J Jeffery
      JASN November 1998, 9 (11) 2129-2134; DOI: https://doi.org/10.1681/ASN.V9112129

S

  1. Saborio, P

    1. Glomerulosclerosis in the remnant kidney rat is modulated by dietary alpha-tocopherol.
      S Hahn, N B Kuemmerle, W Chan, S Hisano, P Saborio, R J Krieg and J C Chan
      JASN November 1998, 9 (11) 2089-2095; DOI: https://doi.org/10.1681/ASN.V9112089

  2. Said, M R

    1. Living unrelated renal transplantation: progress and potential.
      M R Said and J J Curtis
      JASN November 1998, 9 (11) 2148-2152; DOI: https://doi.org/10.1681/ASN.V9112148

  3. Sawin, L L

    1. Effect of endogenous angiotensin II on renal nerve activity and its cardiac baroreflex regulation.
      G F Dibona, S Y Jones and L L Sawin
      JASN November 1998, 9 (11) 1983-1989; DOI: https://doi.org/10.1681/ASN.V9111983

  4. Schnuelle, P

    1. Impact of renal cadaveric transplantation on survival in end-stage renal failure: evidence for reduced mortality risk compared with hemodialysis during long-term follow-up.
      P Schnuelle, D Lorenz, M Trede and F J Van Der Woude
      JASN November 1998, 9 (11) 2135-2141; DOI: https://doi.org/10.1681/ASN.V9112135

  5. Sellmayer, A

    1. High glucose increases prostaglandin E2 synthesis in human peritoneal mesothelial cells: role of hyperosmolarity.
      T Sitter, B Haslinger, S Mandl, H Fricke, E Held and A Sellmayer
      JASN November 1998, 9 (11) 2005-2012; DOI: https://doi.org/10.1681/ASN.V9112005

  6. Shiraishi, F

    1. Linoleyl hydroperoxide transcriptionally upregulates heme oxygenase-1 gene expression in human renal epithelial and aortic endothelial cells.
      A Agarwal, F Shiraishi, G A Visner and H S Nick
      JASN November 1998, 9 (11) 1990-1997; DOI: https://doi.org/10.1681/ASN.V9111990

  7. Sitter, T

    1. High glucose increases prostaglandin E2 synthesis in human peritoneal mesothelial cells: role of hyperosmolarity.
      T Sitter, B Haslinger, S Mandl, H Fricke, E Held and A Sellmayer
      JASN November 1998, 9 (11) 2005-2012; DOI: https://doi.org/10.1681/ASN.V9112005

  8. Skou, J C

    1. The influence of some cations on an adenosine triphosphatase from peripheral nerves.
      J C Skou
      JASN November 1998, 9 (11) 2170-2177; DOI: https://doi.org/10.1681/ASN.V9112170

  9. Solez, K

    1. Beneficial effects of treatment of early subclinical rejection: a randomized study.
      D Rush, P Nickerson, J Gough, R McKenna, P Grimm, M Cheang, K Trpkov, K Solez and J Jeffery
      JASN November 1998, 9 (11) 2129-2134; DOI: https://doi.org/10.1681/ASN.V9112129

  10. Stegeman, C A

    1. Risk factors for long-term renal survival after renal transplantation: a role for angiotensin-converting enzyme (insertion/deletion) polymorphism?
      J Broekroelofs, C A Stegeman, G Navis, A M Tegzess, D De Zeeuw and P E De Jong
      JASN November 1998, 9 (11) 2075-2081; DOI: https://doi.org/10.1681/ASN.V9112075

  11. Steinmann-Niggli, K

    1. Mycophenolic acid: a new approach to the therapy of experimental mesangial proliferative glomerulonephritis.
      R Ziswiler, K Steinmann-Niggli, A Kappeler, C Daniel and H P Marti
      JASN November 1998, 9 (11) 2055-2066; DOI: https://doi.org/10.1681/ASN.V9112055

  12. Sternby, J

    1. Whole body Kt/V from dialysate urea measurements during hemodialysis.
      J Sternby
      JASN November 1998, 9 (11) 2118-2123; DOI: https://doi.org/10.1681/ASN.V9112118

  13. Striker, G E

    1. Glomerular endothelial cells synthesize collagens but little gelatinase A and B.
      O Lenz, L J Striker, T A Jacot, S J Elliot, P D Killen and G E Striker
      JASN November 1998, 9 (11) 2040-2047; DOI: https://doi.org/10.1681/ASN.V9112040

  14. Striker, L J

    1. Glomerular endothelial cells synthesize collagens but little gelatinase A and B.
      O Lenz, L J Striker, T A Jacot, S J Elliot, P D Killen and G E Striker
      JASN November 1998, 9 (11) 2040-2047; DOI: https://doi.org/10.1681/ASN.V9112040

  15. Sugenoya, Y

    1. Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis.
      A Yoshimura, K Inui, T Nemoto, S Uda, Y Sugenoya, S Watanabe, N Yokota, T Taira, S Iwasaki and T Ideura
      JASN November 1998, 9 (11) 2027-2039; DOI: https://doi.org/10.1681/ASN.V9112027

T

  1. Taira, T

    1. Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis.
      A Yoshimura, K Inui, T Nemoto, S Uda, Y Sugenoya, S Watanabe, N Yokota, T Taira, S Iwasaki and T Ideura
      JASN November 1998, 9 (11) 2027-2039; DOI: https://doi.org/10.1681/ASN.V9112027

  2. Tan, D

    1. Role of vascular endothelial growth factor on erythropoietin-related endothelial cell proliferation.
      M V Alvarez Arroyo, M A Castilla, F R González Pacheco, D Tan, A Riesco, S Casado and C Caramelo
      JASN November 1998, 9 (11) 1998-2004; DOI: https://doi.org/10.1681/ASN.V9111998

  3. Tanaka, A

    1. Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins.
      T Kokubo, Y Hiki, H Iwase, A Tanaka, K Toma, K Hotta and Y Kobayashi
      JASN November 1998, 9 (11) 2048-2054; DOI: https://doi.org/10.1681/ASN.V9112048

  4. Tegzess, A M

    1. Risk factors for long-term renal survival after renal transplantation: a role for angiotensin-converting enzyme (insertion/deletion) polymorphism?
      J Broekroelofs, C A Stegeman, G Navis, A M Tegzess, D De Zeeuw and P E De Jong
      JASN November 1998, 9 (11) 2075-2081; DOI: https://doi.org/10.1681/ASN.V9112075

  5. Toma, K

    1. Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins.
      T Kokubo, Y Hiki, H Iwase, A Tanaka, K Toma, K Hotta and Y Kobayashi
      JASN November 1998, 9 (11) 2048-2054; DOI: https://doi.org/10.1681/ASN.V9112048

  6. Trede, M

    1. Impact of renal cadaveric transplantation on survival in end-stage renal failure: evidence for reduced mortality risk compared with hemodialysis during long-term follow-up.
      P Schnuelle, D Lorenz, M Trede and F J Van Der Woude
      JASN November 1998, 9 (11) 2135-2141; DOI: https://doi.org/10.1681/ASN.V9112135

  7. Trpkov, K

    1. Beneficial effects of treatment of early subclinical rejection: a randomized study.
      D Rush, P Nickerson, J Gough, R McKenna, P Grimm, M Cheang, K Trpkov, K Solez and J Jeffery
      JASN November 1998, 9 (11) 2129-2134; DOI: https://doi.org/10.1681/ASN.V9112129

U

  1. Uda, S

    1. Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis.
      A Yoshimura, K Inui, T Nemoto, S Uda, Y Sugenoya, S Watanabe, N Yokota, T Taira, S Iwasaki and T Ideura
      JASN November 1998, 9 (11) 2027-2039; DOI: https://doi.org/10.1681/ASN.V9112027

V

  1. Van Der Woude, F J

    1. Impact of renal cadaveric transplantation on survival in end-stage renal failure: evidence for reduced mortality risk compared with hemodialysis during long-term follow-up.
      P Schnuelle, D Lorenz, M Trede and F J Van Der Woude
      JASN November 1998, 9 (11) 2135-2141; DOI: https://doi.org/10.1681/ASN.V9112135

  2. Visner, G A

    1. Linoleyl hydroperoxide transcriptionally upregulates heme oxygenase-1 gene expression in human renal epithelial and aortic endothelial cells.
      A Agarwal, F Shiraishi, G A Visner and H S Nick
      JASN November 1998, 9 (11) 1990-1997; DOI: https://doi.org/10.1681/ASN.V9111990

W

  1. Watanabe, S

    1. Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis.
      A Yoshimura, K Inui, T Nemoto, S Uda, Y Sugenoya, S Watanabe, N Yokota, T Taira, S Iwasaki and T Ideura
      JASN November 1998, 9 (11) 2027-2039; DOI: https://doi.org/10.1681/ASN.V9112027

  2. Welborn, J R

    1. Peritubular transport of ochratoxin A by single rabbit renal proximal tubules.
      J R Welborn, C E Groves and S H Wright
      JASN November 1998, 9 (11) 1973-1982; DOI: https://doi.org/10.1681/ASN.V9111973

  3. Wright, S H

    1. Peritubular transport of ochratoxin A by single rabbit renal proximal tubules.
      J R Welborn, C E Groves and S H Wright
      JASN November 1998, 9 (11) 1973-1982; DOI: https://doi.org/10.1681/ASN.V9111973

Y

  1. Yokota, N

    1. Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis.
      A Yoshimura, K Inui, T Nemoto, S Uda, Y Sugenoya, S Watanabe, N Yokota, T Taira, S Iwasaki and T Ideura
      JASN November 1998, 9 (11) 2027-2039; DOI: https://doi.org/10.1681/ASN.V9112027

  2. Yoshimura, A

    1. Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis.
      A Yoshimura, K Inui, T Nemoto, S Uda, Y Sugenoya, S Watanabe, N Yokota, T Taira, S Iwasaki and T Ideura
      JASN November 1998, 9 (11) 2027-2039; DOI: https://doi.org/10.1681/ASN.V9112027

Z

  1. Zhang, M Y

    1. Reduced expression of the renal calcium-sensing receptor in rats with experimental chronic renal insufficiency.
      R S Mathias, H T Nguyen, M Y Zhang and A A Portale
      JASN November 1998, 9 (11) 2067-2074; DOI: https://doi.org/10.1681/ASN.V9112067

  2. Ziswiler, R

    1. Mycophenolic acid: a new approach to the therapy of experimental mesangial proliferative glomerulonephritis.
      R Ziswiler, K Steinmann-Niggli, A Kappeler, C Daniel and H P Marti
      JASN November 1998, 9 (11) 2055-2066; DOI: https://doi.org/10.1681/ASN.V9112055
Back to top

In this issue

View Selected Citations (0)